CC BY 4.0 · Rev Bras Ginecol Obstet 2019; 41(06): 412-416
DOI: 10.1055/s-0039-1687861
Case Report
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

A Case of Chronic and Relapsing Paget Disease of the Vulva

1   Department of Dermatovenereology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
Maria Mendonça-Sanches
1   Department of Dermatovenereology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
Luís Soares-de-Almeida
1   Department of Dermatovenereology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
2   Institute of Molecular Medicine, Faculdade de Medicina de Lisboa, Lisboa, Portugal
Isabel Correia-Fonseca
1   Department of Dermatovenereology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
› Institutsangaben
Weitere Informationen


05. Dezember 2018

07. März 2019

24. April 2019 (online)


Extramammary Paget disease is a rare neoplastic condition that more commonly affects postmenopausal Caucasian women. Although the vulvar area is the most frequently affected location, it corresponds solely to 1 to 2% of all vulvar malignancies. A 72-year-old female patient was observed in our outpatient clinic with a 2-year history of an erythematous and pruritic plaque on the vulva. Histopathology and immunohistochemistry studies were compatible with extramammary Paget disease of the vulva. Associated neoplastic conditions were excluded. Due to multiple relapses, the patient was submitted to three surgical interventions, including a total vulvectomy, and to external radiotherapy. The present case illustrates the chronic and recurrent nature of extramammary Paget disease despite aggressive procedures as well as the challenge in obtaining tumor-free resection margins.

  • References

  • 1 Borghi C, Bogani G, Ditto A. , et al. Invasive Paget Disease of the Vulva. Int J Gynecol Cancer 2018; 28 (01) 176-182 . Doi: 10.1097/IGC.0000000000001131
  • 2 Tolia M, Tsoukalas N, Sofoudis C. , et al. Primary extramammary invasive Paget's vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?. BMC Cancer 2016; 16: 563 . Doi: 10.1186/s12885-016-2622-5
  • 3 Matthews N, Wong V, Brooks J, Kroumpouzos G. Genital diseases in the mature woman. Clin Dermatol 2018; 36 (02) 208-221 . Doi: 10.1016/j.clindermatol.2017.10.012
  • 4 Nitecki R, Davis M, Watkins JC. , et al. Extramammary Paget disease of the vulva: A Case Series Examining Treatment, Recurrence, and Malignant Transformation. Int J Gynecol Cancer 2018; 28 (03) 632-638 . Doi: 10.1097/IGC.0000000000001189
  • 5 Chokoeva AA, Tchernev G, Castelli E. , et al. Vulvar cancer: a review for dermatologists. Wien Med Wochenschr 2015; 165 (7-8): 164-177 . Doi: 10.1007/s10354-015-0354-9
  • 6 Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000; 53 (10) 742-749 . Doi: 10.1136/jcp.53.10.742
  • 7 van der Linden M, Meeuwis KAP, Bulten J, Bosse T, van Poelgeest MIE, de Hullu JA. Paget disease of the vulva. Crit Rev Oncol Hematol 2016; 101: 60-74 . Doi: 10.1016/j.critrevonc.2016.03.008
  • 8 Dogan A, Hilal Z, Krentel H. , et al. Paget's Disease of the Vulva Treated with Imiquimod: Case Report and Systematic Review of the Literature. Gynecol Obstet Invest 2017; 82 (01) 1-7 . Doi: 10.1159/000449158
  • 9 Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A. Interventions for the treatment of Paget's disease of the vulva. Cochrane Database Syst Rev 2013; ; ( (10) CD009245 . Doi: 10.1002/14651858.CD009245.pub2
  • 10 Tomar TS, Sambasivan S, Nair RP, Thomas S, Ramadas PT. Extra Mammary Paget's Disease of Vulva-a Case Report. Indian J Surg Oncol 2016; 7 (04) 488-490 . Doi: 10.1007/s13193-016-0551-z
  • 11 Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002; 33 (05) 549-554 . Doi: 10.1053/hupa.2002.124788
  • 12 Onaiwu CO, Salcedo MP, Pessini SA. , et al. Paget's disease of the vulva: A review of 89 cases. Gynecol Oncol Rep 2016; 19: 46-49 . Doi: 10.1016/j.gore.2016.12.010
  • 13 Ito T, Kaku-Ito Y, Furue M. The diagnosis and management of extramammary Paget's disease. Expert Rev Anticancer Ther 2018; 18 (06) 543-553 . Doi: 10.1080/14737140.2018.1457955
  • 14 Fan L, Zhu J, Tao X, Xu C. Intraepithelial Extramammary Paget's Disease of the Vulva: The Clinicopathological Characteristics, Management, and Outcome in a Study of 18 Female Patients. Dermatol Surg 2016; 42 (10) 1142-1146 . Doi: 10.1097/DSS.0000000000000903
  • 15 Tagliaferri L, Casà C, Macchia G. , et al. The Role of Radiotherapy in Extramammary Paget Disease: A Systematic Review. Int J Gynecol Cancer 2018; 28 (04) 829-839 . Doi: 10.1097/IGC.0000000000001237
  • 16 Del Castillo LF, Garcia C, Schoendorff C, Garcia JF, Torres LM, Garcia Almagro D. Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget's disease: response to topical 5-fluorouracil. Cutis 2000; 65 (05) 331-333
  • 17 Cowan RA, Black DR, Hoang LN. , et al. A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease. Gynecol Oncol 2016; 142 (01) 139-143 . Doi: 10.1016/j.ygyno.2016.04.028
  • 18 Eliezri YD, Silvers DN, Horan DB. Role of preoperative topical 5-fluorouracil in preparation for Mohs micrographic surgery of extramammary Paget's disease. J Am Acad Dermatol 1987; 17 (03) 497-505 . Doi: 10.1016/S0190-9622(87)70236-9
  • 19 Bewley AP, Bracka A, Staughton RC, Bunker CB. Extramammary Paget's disease of the scrotum: treatment with topical 5-fluorouracil and plastic surgery. Br J Dermatol 1994; 131 (03) 445-446 . Doi: 10.1111/j.1365-2133.1994.tb08535.x
  • 20 Ye JN, Rhew DC, Yip F, Edelstein L. Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: a case report. Cutis 2006; 77 (04) 245-250
  • 21 Kato H, Watanabe S, Kariya K, Nakamura M, Morita A. Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease. J Dermatol 2018; 45 (05) 560-563 . Doi: 10.1111/1346-8138.14247
  • 22 Chen K, Liang H, Peng J, Zheng Y. Successful treatment of metastatic extramammary Paget's disease with pemetrexed monotherapy systemically and 5-fluorouracil topically. Indian J Dermatol Venereol Leprol 2019; 85 (01) 56-59 . Doi: 10.4103/ijdvl.IJDVL_171_17
  • 23 Flowers F. Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms. Int J Dermatol 2002; 41 (Suppl. 01) 12-15 . Doi: 10.1111/j.1365-4632.2002.00019.x
  • 24 Anton C, Luiz AV, Carvalho FM, Baracat EC, Carvalho JP. Clinical treatment of vulvar Paget's disease: a case report. Clinics (São Paulo) 2011; 66 (06) 1109-1111 . Doi: 10.1590/S1807-59322011000600033
  • 25 Marchitelli C, Peremateu MS, Sluga MC. , et al. Treatment of primary vulvar paget disease with 5% imiquimod cream. J Low Genit Tract Dis 2014; 18 (04) 347-350 . Doi: 10.1097/LGT.0000000000000053
  • 26 Mirer E, El Sayed F, Ammoury A, Lamant L, Messer L, Bazex J. Treatment of mammary and extramammary Paget's skin disease with topical imiquimod. J Dermatolog Treat 2006; 17 (03) 167-171 . Doi: 10.1080/09546630600788877
  • 27 Luyten A, Sörgel P, Clad A. , et al. Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network. J Am Acad Dermatol 2014; 70 (04) 644-650 . Doi: 10.1016/j.jaad.2013.12.008
  • 28 Machida H, Moeini A, Roman LD, Matsuo K. Effects of imiquimod on vulvar Paget's disease: a systematic review of literature. Gynecol Oncol 2015; 139 (01) 165-171 . Doi: 10.1016/j.ygyno.2015.07.097
  • 29 van der Linden M, Meeuwis K, van Hees C. , et al. The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease. JMIR Res Protoc 2017; 6 (09) e178 . Doi: 10.2196/resprot.7503